Hemophilia a Trials in Los Angeles, United States
Conditions / Hemophilia a / Los Angeles, United States
Hemophilia a has been the subject of sustained clinical investigation across multiple research sites.
39 total trials for this combination
Showing top 10 of 39 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00214734 | ADVATE Post Authorization Safety Surveillance | COMPLETED | — |
| NCT00157157 | Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients | COMPLETED | PHASE3 |
| NCT05911763 | A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A | ACTIVE_NOT_RECRUITING | — |
| NCT03370913 | Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301) | COMPLETED | PHASE3 |
| NCT01454739 | Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A | COMPLETED | PHASE3 |
| NCT02585960 | BAX 855 PK-guided Dosing | COMPLETED | PHASE3 |
| NCT03417102 | A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors | COMPLETED | PHASE3 |
| NCT02622321 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors | COMPLETED | PHASE3 |
| NCT04644575 | Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04759131 | Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A | COMPLETED | PHASE3 |